Request for Covid-19 Impact Assessment of this Report

Consumer Goods

United States Female Contraceptive Products Market Report 2016

  • QYR758890
  • 119 Pages
  • November 2016
  • Consumer Goods
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Female Contraceptive Products

Revenue, means the sales value of Female Contraceptive Products

This report studies sales (consumption) of Female Contraceptive Products in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Allergan

Merck Millipore

Pfizer

Teva Pharmaceuticals

Afaxys

Agile Therapeutics

Ansell

Bayer Pharma

Caya

Ferring Pharmaceuticals

Female Health

Fuji Latex

HLL Lifecare

Janssen Pharmaceuticals

Lipocine

Lupin Pharmaceuticals

Mayer Laboratories

Okamoto Industries

Reckitt Benckiser

Syzygy Healthcare

V-Care Pharma

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by applications, this report focuses on sales, market share and growth rate of Female Contraceptive Products in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

United States Female Contraceptive Products Market Report 2016

1 Female Contraceptive Products Overview

1.1 Product Overview and Scope of Female Contraceptive Products

1.2 Classification of Female Contraceptive Products

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Female Contraceptive Products

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Female Contraceptive Products (2011-2021)

1.4.1 United States Female Contraceptive Products Sales and Growth Rate (2011-2021)

1.4.2 United States Female Contraceptive Products Revenue and Growth Rate (2011-2021)

2 United States Female Contraceptive Products Competition by Manufacturers

2.1 United States Female Contraceptive Products Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Female Contraceptive Products Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Female Contraceptive Products Average Price by Manufactures (2015 and 2016)

2.4 Female Contraceptive Products Market Competitive Situation and Trends

2.4.1 Female Contraceptive Products Market Concentration Rate

2.4.2 Female Contraceptive Products Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Female Contraceptive Products Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Female Contraceptive Products Sales and Market Share by Type (2011-2016)

3.2 United States Female Contraceptive Products Revenue and Market Share by Type (2011-2016)

3.3 United States Female Contraceptive Products Price by Type (2011-2016)

3.4 United States Female Contraceptive Products Sales Growth Rate by Type (2011-2016)

4 United States Female Contraceptive Products Sales (Volume) by Application (2011-2016)

4.1 United States Female Contraceptive Products Sales and Market Share by Application (2011-2016)

4.2 United States Female Contraceptive Products Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States Female Contraceptive Products Manufacturers Profiles/Analysis

5.1 Allergan

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Female Contraceptive Products Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Allergan Female Contraceptive Products Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Merck Millipore

5.2.2 Female Contraceptive Products Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Merck Millipore Female Contraceptive Products Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Pfizer

5.3.2 Female Contraceptive Products Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Pfizer Female Contraceptive Products Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Teva Pharmaceuticals

5.4.2 Female Contraceptive Products Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Teva Pharmaceuticals Female Contraceptive Products Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Afaxys

5.5.2 Female Contraceptive Products Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Afaxys Female Contraceptive Products Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Agile Therapeutics

5.6.2 Female Contraceptive Products Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Agile Therapeutics Female Contraceptive Products Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Ansell

5.7.2 Female Contraceptive Products Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Ansell Female Contraceptive Products Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Bayer Pharma

5.8.2 Female Contraceptive Products Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Bayer Pharma Female Contraceptive Products Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Caya

5.9.2 Female Contraceptive Products Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Caya Female Contraceptive Products Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Ferring Pharmaceuticals

5.10.2 Female Contraceptive Products Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Ferring Pharmaceuticals Female Contraceptive Products Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 Female Health

5.12 Fuji Latex

5.13 HLL Lifecare

5.14 Janssen Pharmaceuticals

5.15 Lipocine

5.16 Lupin Pharmaceuticals

5.17 Mayer Laboratories

5.18 Okamoto Industries

5.19 Reckitt Benckiser

5.20 Syzygy Healthcare

5.21 V-Care Pharma

6 Female Contraceptive Products Manufacturing Cost Analysis

6.1 Female Contraceptive Products Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Female Contraceptive Products

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Female Contraceptive Products Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Female Contraceptive Products Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States Female Contraceptive Products Market Forecast (2016-2021)

10.1 United States Female Contraceptive Products Sales, Revenue Forecast (2016-2021)

10.2 United States Female Contraceptive Products Sales Forecast by Type (2016-2021)

10.3 United States Female Contraceptive Products Sales Forecast by Application (2016-2021)

10.4 Female Contraceptive Products Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Disclosure Section

Research Methodology

Data Source

Disclaimer

List of Tables and Figures

Figure Picture of Female Contraceptive Products

Table Classification of Female Contraceptive Products

Figure United States Sales Market Share of Female Contraceptive Products by Type in 2015

Table Application of Female Contraceptive Products

Figure United States Sales Market Share of Female Contraceptive Products by Application in 2015

Figure United States Female Contraceptive Products Sales and Growth Rate (2011-2021)

Figure United States Female Contraceptive Products Revenue and Growth Rate (2011-2021)

Table United States Female Contraceptive Products Sales of Key Manufacturers (2015 and 2016)

Table United States Female Contraceptive Products Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Female Contraceptive Products Sales Share by Manufacturers

Figure 2016 Female Contraceptive Products Sales Share by Manufacturers

Table United States Female Contraceptive Products Revenue by Manufacturers (2015 and 2016)

Table United States Female Contraceptive Products Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Female Contraceptive Products Revenue Share by Manufacturers

Table 2016 United States Female Contraceptive Products Revenue Share by Manufacturers

Table United States Market Female Contraceptive Products Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Female Contraceptive Products Average Price of Key Manufacturers in 2015

Figure Female Contraceptive Products Market Share of Top 3 Manufacturers

Figure Female Contraceptive Products Market Share of Top 5 Manufacturers

Table United States Female Contraceptive Products Sales by Type (2011-2016)

Table United States Female Contraceptive Products Sales Share by Type (2011-2016)

Figure United States Female Contraceptive Products Sales Market Share by Type in 2015

Table United States Female Contraceptive Products Revenue and Market Share by Type (2011-2016)

Table United States Female Contraceptive Products Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Female Contraceptive Products by Type (2011-2016)

Table United States Female Contraceptive Products Price by Type (2011-2016)

Figure United States Female Contraceptive Products Sales Growth Rate by Type (2011-2016)

Table United States Female Contraceptive Products Sales by Application (2011-2016)

Table United States Female Contraceptive Products Sales Market Share by Application (2011-2016)

Figure United States Female Contraceptive Products Sales Market Share by Application in 2015

Table United States Female Contraceptive Products Sales Growth Rate by Application (2011-2016)

Figure United States Female Contraceptive Products Sales Growth Rate by Application (2011-2016)

Table Allergan Basic Information List

Table Allergan Female Contraceptive Products Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Allergan Female Contraceptive Products Sales Market Share (2011-2016)

Table Merck Millipore Basic Information List

Table Merck Millipore Female Contraceptive Products Sales, Revenue, Price and Gross Margin (2011-2016)

Table Merck Millipore Female Contraceptive Products Sales Market Share (2011-2016)

Table Pfizer Basic Information List

Table Pfizer Female Contraceptive Products Sales, Revenue, Price and Gross Margin (2011-2016)

Table Pfizer Female Contraceptive Products Sales Market Share (2011-2016)

Table Teva Pharmaceuticals Basic Information List

Table Teva Pharmaceuticals Female Contraceptive Products Sales, Revenue, Price and Gross Margin (2011-2016)

Table Teva Pharmaceuticals Female Contraceptive Products Sales Market Share (2011-2016)

Table Afaxys Basic Information List

Table Afaxys Female Contraceptive Products Sales, Revenue, Price and Gross Margin (2011-2016)

Table Afaxys Female Contraceptive Products Sales Market Share (2011-2016)

Table Agile Therapeutics Basic Information List

Table Agile Therapeutics Female Contraceptive Products Sales, Revenue, Price and Gross Margin (2011-2016)

Table Agile Therapeutics Female Contraceptive Products Sales Market Share (2011-2016)

Table Ansell Basic Information List

Table Ansell Female Contraceptive Products Sales, Revenue, Price and Gross Margin (2011-2016)

Table Ansell Female Contraceptive Products Sales Market Share (2011-2016)

Table Bayer Pharma Basic Information List

Table Bayer Pharma Female Contraceptive Products Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bayer Pharma Female Contraceptive Products Sales Market Share (2011-2016)

Table Caya Basic Information List

Table Caya Female Contraceptive Products Sales, Revenue, Price and Gross Margin (2011-2016)

Table Caya Female Contraceptive Products Sales Market Share (2011-2016)

Table Ferring Pharmaceuticals Basic Information List

Table Ferring Pharmaceuticals Female Contraceptive Products Sales, Revenue, Price and Gross Margin (2011-2016)

Table Ferring Pharmaceuticals Female Contraceptive Products Sales Market Share (2011-2016)

Table Female Health Basic Information List

Table Female Health Female Contraceptive Products Sales, Revenue, Price and Gross Margin (2011-2016)

Table Female Health Female Contraceptive Products Sales Market Share (2011-2016)

Table Fuji Latex Basic Information List

Table Fuji Latex Female Contraceptive Products Sales, Revenue, Price and Gross Margin (2011-2016)

Table Fuji Latex Female Contraceptive Products Sales Market Share (2011-2016)

Table HLL Lifecare Basic Information List

Table HLL Lifecare Female Contraceptive Products Sales, Revenue, Price and Gross Margin (2011-2016)

Table HLL Lifecare Female Contraceptive Products Sales Market Share (2011-2016)

Table Janssen Pharmaceuticals Basic Information List

Table Janssen Pharmaceuticals Female Contraceptive Products Sales, Revenue, Price and Gross Margin (2011-2016)

Table Janssen Pharmaceuticals Female Contraceptive Products Sales Market Share (2011-2016)

Table Lipocine Basic Information List

Table Lipocine Female Contraceptive Products Sales, Revenue, Price and Gross Margin (2011-2016)

Table Lipocine Female Contraceptive Products Sales Market Share (2011-2016)

Table Lupin Pharmaceuticals Basic Information List

Table Lupin Pharmaceuticals Female Contraceptive Products Sales, Revenue, Price and Gross Margin (2011-2016)

Table Lupin Pharmaceuticals Female Contraceptive Products Sales Market Share (2011-2016)

Table Mayer Laboratories Basic Information List

Table Mayer Laboratories Female Contraceptive Products Sales, Revenue, Price and Gross Margin (2011-2016)

Table Mayer Laboratories Female Contraceptive Products Sales Market Share (2011-2016)

Table Okamoto Industries Basic Information List

Table Okamoto Industries Female Contraceptive Products Sales, Revenue, Price and Gross Margin (2011-2016)

Table Okamoto Industries Female Contraceptive Products Sales Market Share (2011-2016)

Table Reckitt Benckiser Basic Information List

Table Reckitt Benckiser Female Contraceptive Products Sales, Revenue, Price and Gross Margin (2011-2016)

Table Reckitt Benckiser Female Contraceptive Products Sales Market Share (2011-2016)

Table Syzygy Healthcare Basic Information List

Table Syzygy Healthcare Female Contraceptive Products Sales, Revenue, Price and Gross Margin (2011-2016)

Table Syzygy Healthcare Female Contraceptive Products Sales Market Share (2011-2016)

Table V-Care Pharma Basic Information List

Table V-Care Pharma Female Contraceptive Products Sales, Revenue, Price and Gross Margin (2011-2016)

Table V-Care Pharma Female Contraceptive Products Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Female Contraceptive Products

Figure Manufacturing Process Analysis of Female Contraceptive Products

Figure Female Contraceptive Products Industrial Chain Analysis

Table Raw Materials Sources of Female Contraceptive Products Major Manufacturers in 2015

Table Major Buyers of Female Contraceptive Products

Table Distributors/Traders List

Figure United States Female Contraceptive Products Production and Growth Rate Forecast (2016-2021)

Figure United States Female Contraceptive Products Revenue and Growth Rate Forecast (2016-2021)

Table United States Female Contraceptive Products Production Forecast by Type (2016-2021)

Table United States Female Contraceptive Products Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

World Refrigerated Display Cases Market - Opportunities and Forecasts, 2015 - 2022

Refrigerated display cases are cabinets with glass surfaces for items, which require cooling or preservation. The cases are ideal for products requiring a regulated temperature to maintain the freshness. These are mostly used in retail stores and food & re...

  • Publish Date: May 5, 2016
  • $5370
World Probiotics Market - Opportunities and Forecasts, 2014-2022

Probiotics are microorganisms, such as bacteria and yeast, that are very useful to sustain the balance of intestinal microbial in human and animal body. Probiotic ingredients stimulate natural digestive juices and enzymes in the body to ensure proper functio...

  • Publish Date: August 1, 2016
  • $5370
Wearable Technology Market by Device (Smart watch, fitness & wellness devices, Smart glasses, Smart clothing), by Product type (Wrist wear, eyewear, hearables, neckwear, bodywear) and Geography - Global Opportunity Analysis and Industry Forecast, 2014-2022

Wearable technology refers to electronics devices that are designed to be worn anywhere around the body thereby enabling hands free operations. Wearable technology products have gained popularity over the past few years, with advancements in technology an...

  • Publish Date: April 6, 2017
  • $5370